- Home
- CMPO vs FOLD Comparison
CMPO vs FOLD Comparison
Compare CMPO & FOLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMPO
- FOLD
- Stock Information
- Founded
- CMPO 2000
- FOLD 2002
- Country
- CMPO United States
- FOLD United States
- Employees
- CMPO N/A
- FOLD N/A
- Industry
- CMPO Finance: Consumer Services
- FOLD Biotechnology: Pharmaceutical Preparations
- Sector
- CMPO Finance
- FOLD Health Care
- Exchange
- CMPO Nasdaq
- FOLD Nasdaq
- Market Cap
- CMPO 2.1B
- FOLD 2.5B
- IPO Year
- CMPO N/A
- FOLD 2007
- Fundamental
- Price
- CMPO $20.18
- FOLD $8.15
- Analyst Decision
- CMPO Strong Buy
- FOLD Strong Buy
- Analyst Count
- CMPO 6
- FOLD 9
- Target Price
- CMPO $17.67
- FOLD $26.44
- AVG Volume (30 Days)
- CMPO 1.0M
- FOLD 5.8M
- Earning Date
- CMPO 11-07-2025
- FOLD 11-05-2025
- Dividend Yield
- CMPO N/A
- FOLD N/A
- EPS Growth
- CMPO N/A
- FOLD N/A
- EPS
- CMPO N/A
- FOLD N/A
- Revenue
- CMPO $267,817,999.00
- FOLD $571,160,000.00
- Revenue This Year
- CMPO $10.30
- FOLD $20.98
- Revenue Next Year
- CMPO $8.12
- FOLD $20.74
- P/E Ratio
- CMPO N/A
- FOLD N/A
- Revenue Growth
- CMPO N/A
- FOLD 25.35
- 52 Week Low
- CMPO $9.24
- FOLD $5.51
- 52 Week High
- CMPO $21.00
- FOLD $12.65
- Technical
- Relative Strength Index (RSI)
- CMPO 56.24
- FOLD 56.40
- Support Level
- CMPO $19.71
- FOLD $7.69
- Resistance Level
- CMPO $20.87
- FOLD $8.59
- Average True Range (ATR)
- CMPO 0.68
- FOLD 0.37
- MACD
- CMPO -0.15
- FOLD -0.05
- Stochastic Oscillator
- CMPO 37.86
- FOLD 54.44
About CMPO CompoSecure Inc.
CompoSecure Inc is engaged in designing and manufacturing premium financial cards. The Company's metal payment card technology and Arculus security and authentication capabilities deliver premium branded experiences which enable people to access and use their assets, and ensure trust at the point of a transaction. Its products include Metal Cards and Arculus, a digital security platform. It has two reportable segments: Payment Card and Arculus.
About FOLD Amicus Therapeutics Inc.
Amicus Therapeutics Inc is a patient-dedicated biotechnology company focused on discovering, developing and delivering novel high-quality medicines for people living with rare diseases. With extraordinary patient focus, the company is committed to advancing and expanding a pipeline of cutting-edge medicines for rare diseases. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; a clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. The company has one segment focused on the discovery, development, and commercialization of therapies to treat a range of devastating rare and orphan diseases.